ARTICLE | Clinical News
Antisoma preclinical data
December 3, 2001 8:00 AM UTC
ASOM published in Radiation Research that treatment with DMXAA increased the anti-tumor effects of radiotherapy in mouse models of breast cancer and sarcomas. The product, which is in Phase I trials t...